- $887.18m
- $611.92m
- $90.24m
- 45
- 10
- 70
- 37
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 35.2 | 155 | 470 | 113 | 90.2 |
Cost of Revenue | |||||
Gross Profit | 27 | 119 | 419 | 58.2 | 53 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 184 | 274 | 310 | 376 | 358 |
Operating Profit | -149 | -119 | 160 | -263 | -268 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -97.5 | -106 | 141 | -280 | -264 |
Provision for Income Taxes | |||||
Net Income After Taxes | -94.7 | -111 | 128 | -280 | -263 |
Net Income Before Extraordinary Items | |||||
Net Income | -94.7 | -111 | 128 | -280 | -263 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -94.7 | -111 | 128 | -280 | -263 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.58 | -2.98 | 2.91 | -6.5 | -6.02 |